SCHEMBL29522124

SCHEMBL29522124

Cc1cc(OC(F)(F)F)ccc1NC(=O)C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.46
KDR P35968 4/20 0.45
BRAF P15056 2/20 0.45
EPHX2 P34913 1/20 0.45
ALDH1A1 P00352 2/20 0.45
POLB P06746 1/20 0.45
GAA P10253 1/20 0.45
THRB P10828 1/20 0.45
RAB9A P51151 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
IGF2BP2 Q9Y6M1 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ABCC9 O60706 2/20 0.41
ABCC8 Q09428 2/20 0.41
KCNJ11 Q14654 2/20 0.41
KCNJ8 Q15842 2/20 0.41
DYRK1A Q13627 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19411046 1.00 DHODH (0.46) DHODHKDRBRAFEPHX2ALDH1A1
SCHEMBL7383350 0.88 DHODH (0.51) DHODHKDRBRAFEPHX2ALDH1A1
SCHEMBL28139470 0.86 DYRK1A (0.51) DHODHKDRBRAFEPHX2ALDH1A1
SCHEMBL23885462 0.82 IGF2BP2 (0.45) DHODHEPHX2ALDH1A1POLBGAA
SCHEMBL30254114 0.82 IGF2BP2 (0.45) DHODHEPHX2ALDH1A1POLBGAA
SCHEMBL7665668 0.81 KCNQ3 (0.46) DHODHKDRBRAFEPHX2ALDH1A1
SCHEMBL11726016 0.81 RAB9A (0.41) ALDH1A1RAB9ACYP1A2CYP2C9CYP2C19
SCHEMBL27054662 0.81 IGF2BP2 (0.63) DHODHEPHX2ALDH1A1POLBGAA
SCHEMBL6676510 0.80 IGF2BP2 (0.62) DHODHPOLBGAARAB9ACYP1A2
SCHEMBL20565746 0.79 KMT2A (0.53) DHODHKDRBRAFALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702387-B2 Substituted indoline derivatives as dengue viral replication inhibitors Janssen Pharmaceuticals, Inc. (US) 2023-07-18 US disclosed
CN-110461831-B Substituted indoline derivatives as inhibitors of dengue virus replication 杨森制药公司 2022-11-01 CN disclosed
EP-3436436-B1 SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS JANSSEN PHARMACEUTICALS INC (US) 2022-05-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702387-B2 Substituted indoline derivatives as dengue viral replication inhibitors IDO1, INMT, IRF3 DHODH 53/4885KDR 494/4885BRAF 3270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.